Ken Griffin
APRE icon

Ken Griffin’s Aprea Therapeutics APRE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,083
Closed -$61.4K 5809
2025
Q1
$61.4K Buy
+30,083
New +$61.4K ﹤0.01% 5308
2023
Q1
Sell
-1,276
Closed -$411 5891
2022
Q4
$411 Buy
+1,276
New +$411 ﹤0.01% 5960
2022
Q3
Sell
-18,881
Closed -$14K 5840
2022
Q2
$14K Sell
18,881
-58,201
-76% -$43.2K ﹤0.01% 5775
2022
Q1
$143K Sell
77,082
-86,179
-53% -$160K ﹤0.01% 5477
2021
Q4
$469K Buy
163,261
+41,312
+34% +$119K ﹤0.01% 4673
2021
Q3
$623K Buy
121,949
+93,330
+326% +$477K ﹤0.01% 4293
2021
Q2
$140K Buy
+28,619
New +$140K ﹤0.01% 5784
2021
Q1
Hold
0
6233
2020
Q4
Sell
-74,073
Closed -$1.78M 5044
2020
Q3
$1.78M Sell
74,073
-234,875
-76% -$5.65M ﹤0.01% 2384
2020
Q2
$12M Sell
308,948
-12,293
-4% -$477K ﹤0.01% 993
2020
Q1
$11.2M Buy
321,241
+12,229
+4% +$425K 0.01% 927
2019
Q4
$14.2M Buy
+309,012
New +$14.2M 0.01% 987